Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.

Raza, A; Alvi, S; Broady-Robinson, L; Showel, M; Cartlidge, J; Mundle, S D; Shetty, V T; Borok, R Z; Dar, S E; Chopra, H K; Span, L; Parcharidou, A; Hines, C; Gezer, S; Venugopal, P; Loew, J; Showel, J; Alston, D; Hernandez, B; Rifkin, S; Robin, E; Shah, R; Gregory, S A

Raza, A; Alvi, S; Broady-Robinson, L; Showel, M; Cartlidge, J; Mundle, S D; Shetty, V T; Borok, R Z; Dar, S E; Chopra, H K; Span, L; Parcharidou, A; Hines, C; Gezer, S; Venugopal, P; Loew, J; Showel, J; Alston, D; Hernandez, B; Rifkin, S; Robin, E; Shah, R; Gregory, S A.

Afiliación

Raza A; Rush Cancer Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612-3824, USA.

Exp Hematol ; 25(6): 530-5, 1997 Jun.

Article en En | MEDLINE | ID: mdl-9197332

Asunto(s)

Bromodesoxiuridina; Ciclo Celular; Idoxuridina; Síndromes Mielodisplásicos/patología; Apoptosis; ADN/biosíntesis; Humanos

Buscar en Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Bromodesoxiuridina / Ciclo Celular / Idoxuridina Límite: Humans Idioma: En Revista: Exp Hematol Año: 1997 Tipo del documento: Article País de afiliación: Estados Unidos

Buscar en Google

Imprimir

XML

PubMed Links